Dogwood Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132K Sell
1,030
-97
-9% -$11.4K 0.05% 92
2026
Q1
$136K Buy
1,127
+87
+8% +$10K 0.06% 104
2025
Q4
$110K Sell
1,040
-131
-11% -$12.3K 0.05% 104
2025
Q3
$99.3K Buy
1,171
+161
+16% +$13.3K 0.05% 104
2025
Q2
$82.2K Buy
1,010
+170
+20% +$13.5K 0.04% 104
2025
Q1
$76.2K Buy
840
+21
+3% +$1.96K 0.04% 103
2024
Q4
$81.5K Buy
819
+4
+0.5% +$412 0.04% 104
2024
Q3
$92.6K Buy
815
+4
+0.5% +$475 0.05% 102
2024
Q2
$100K Buy
811
+5
+0.6% +$644 0.06% 97
2024
Q1
$106K Buy
806
+5
+0.6% +$616 0.07% 102
2023
Q4
$87.5K Buy
+801
New +$83.1K 0.07% 99

Other funds holding MRK

Dogwood Wealth Management's MRK Position: Q2 2026 in Review

Dogwood Wealth Management reduced its Merck (MRK) stake by 8.6% in Q2 2026, selling an estimated $11.4K and leaving 1,030 shares worth $132K. The position accounts for 0.05% of the portfolio, ranked #92.

Dogwood Wealth Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $136K in Q1 2026. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Dogwood Wealth Management held 1,030 shares of Merck worth $132K as of Q2 2026.
  • Dogwood Wealth Management sold 97 Merck shares in Q2 2026, an estimated $11.4K.
  • Merck made up 0.05% of Dogwood Wealth Management's portfolio in Q2 2026, its #92 holding.
  • Dogwood Wealth Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Dogwood Wealth Management's Merck position peaked at $136K in Q1 2026.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.